Position in BTAI
as of Mar 31, 2026
· filed May 20, 2026
Position Value
$57,503
-$11,157 QoQ
Shares Held
42,913
0.0% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#14
of 40 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Oaktree Fund Advisors, LLC holds $804,087 across 2 Drug Manufacturers - Specialty & Generic names. BTAI ranks #2 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALVO |
Alvotech
|
217,663 | $746,584 | |
| 2 | BTAI |
BioXcel Therapeutics, Inc.
This page
|
42,913 | $57,503 |
All Filings in BTAI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $57,503 | 42,913 | Shares | Defined | 2026-05-20 | |
| 2025-12-31 | $68,660 | 42,913 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $109,857 | 42,913 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $77,672 | 42,913 | Shares | Defined | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||